基于估计信息时间权重的样本量重新估计方法
熊航乐 , 巩浩雯 , 刘玉秀 , 王静怡 , 倪咏天 , 李维勤
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (7) : 885 -891.
基于估计信息时间权重的样本量重新估计方法
Sample size re-estimation method based on estimated information time weighting
目的: 提出一种新的条件把握度(conditional power,CP)算法,并用于样本量重新估计(sample size re-estimation,SSR)。方法: 根据期中观察到的结果估计出一个临时样本量,然后以当前样本量占该估计样本量的比例作为权重,即估计信息时间权重(estimated information time weighting,EIW),计算 CP(cpEIW)并进行样本量重新估计。借助 Monte-Carlo 模拟技术对该方法与目前计算 CP 常用的cpI法(初始假定参数法)、cpD法(期中观测结果法)和cpOPW法(最优混合权重法)3 种方法进行准确性比较,并比较基于 4 种 CP 算法进行样本量重新估计的统计性能。结果: 对 CP 准确性的模拟结果显示,cpEIW和cpT的准确性接近,且两者均优于常用的cpI和cpD。对基于不同 CP 算法进行样本量重新估计的模拟结果显示,4 种方法均能够控制一类错误,而cpEIW法具有最高的把握度,同时具有最优的平均性能得分(APS)。结论: 在 4 种 CP 算法中,cpEIW法具有较好的准确性,用其进行样本量重新估计也具有较好的统计性能,可推荐应用。
AIM: To propose a new conditional power (CP) algorithm and apply it to sample size re-estimation (SSR). METHODS: A temporary sample size was estimated based on the interim observed results, and the ratio of the current sample size to this estimated sample size was used as the weight, referred to as the estimated information time weighting (EIW). CP (cpEIW) was calculated using this weighting, and sample size re-estimation is performed. Monte Carlo simulation techniques were used to compare the accuracy of this method with three commonly used CP calculation methods: cpI method (initial assumed parameter method), cpD method (interim observation result method), and cpOPW method (optimal hybrid weight method). Additionally, the statistical performance of sample size re-estimation based on four different CP algorithms was compared. RESULTS: Simulation results for CP accuracy showed that the accuracy of cpEIW and cpT were close, and both outperform the commonly used cpI and cpD. For sample size re-estimation based on different CP algorithms, all four methods were able to control type Ⅰ error, with cpEIW showing the highest conditional power and the best average performance score (APS). CONCLUSION: Among the four CP algorithms, cpEIW exhibits good accuracy and provides better statistical performance for sample size re-estimation. It is recommended for application.
| [1] |
国家药品监督管理局药品评审中心. 药物临床试验适应性设计指导原则 (试行)[EB/OL]. (2021-01-29)[2024-12-10].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=4409e51a403a911757af6caf3ecef129. |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
Glimm E. Comments on ‘Adaptive increase in sample size when interim results are promising: a practical guide with examples’[J].Stat Med, 2012, 31(1): 98-99. |
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
国家自然科学基金面上项目(81473066)
/
| 〈 |
|
〉 |